| 621 |
Centers for Disease Control and Prevention |
Html |
en |
Test Your Knowledge: Sickle Cell Disease - CDC Features |
September is Sickle Cell Disease (SCD) Awareness Month. How much do you know about SCD? Take a quiz to find out and learn about the Centers for Disease Control and Prevention’s (CDC’s) work. |
| CDC.gov Current Features | 0.906892 |
|
|
CLICK HERE |
| 4534 |
Centers for Disease Control and Prevention |
Html |
en |
HIV/AIDS and the Flu |
People with HIV/AIDS are at increased risk of from serious complications from flu - CDC |
| influenza infection | 0.501945 |
| influenza antiviral agents | 0.63814 |
| influenza antiviral drugs | 0.667501 |
| influenza-related complications | 0.515811 |
| HIV-infected persons | 0.42386 |
| influenza symptoms | 0.516587 |
| ) site. | 0.403636 |
| HIV attacks cells | 0.495183 |
| antiviral chemoprophylaxis agents | 0.423702 |
| example people | 0.271816 |
| influenza vaccine | 0.772204 |
| seasonal influenza | 0.451262 |
| Current CDC guidance | 0.339385 |
| certain cancers | 0.257269 |
| AIDS | 0.324424 |
| lung-related hospitalizations | 0.258934 |
| flu antiviral drugs | 0.607227 |
| severe paralyzing illness | 0.35283 |
| active antiretroviral therapy | 0.382402 |
| life-threatening allergic reaction | 0.355979 |
| adverse drug reactions | 0.339672 |
| inactivated influenza vaccine | 0.708354 |
| live influenza virus | 0.579897 |
| high risk | 0.524724 |
| human immunodeficiency virus | 0.401732 |
|
| antiviral medications | 0.468161 |
| advanced HIV disease | 0.466354 |
| influenza | 0.945315 |
| milder egg allergies | 0.357093 |
| United States | 0.261501 |
| flu vaccine | 0.692463 |
| flu complications | 0.533244 |
| certain people | 0.294613 |
| flu shots | 0.448588 |
| immune response | 0.399622 |
| immunodeficiency syndrome | 0.269297 |
| health care workers | 0.515621 |
| influenza season | 0.515875 |
| greater chance | 0.360241 |
| certain HIV-infected people | 0.492132 |
| people | 0.703661 |
| influenza vaccination | 0.628795 |
| flu | 0.81856 |
| local public health | 0.337326 |
| nasal spray vaccine | 0.430377 |
| flu shot | 0.452227 |
| HIV | 0.586511 |
| influenza viruses | 0.510023 |
| poor immune response | 0.373602 |
|
CLICK HERE |
| 5833 |
Centers for Disease Control and Prevention |
Html |
en |
Vinyl toluene - NIOSH Pocket Guide to Chemical Hazards |
null |
| MPEG | 0.378858 |
| search | 0.263099 |
| PDF | 0.261307 |
| PPT | 0.446092 |
|
| DOC | 0.368812 |
| information | 0.262482 |
| different file formats | 0.938484 |
| page | 0.276773 |
|
CLICK HERE |
| 6892 |
Centers for Disease Control and Prevention |
Html |
en |
Information for Specific Groups|Extreme Heat |
Information on extreme heat. Provided by the Centers for Disease Control and Prevention (CDC). |
| Microsoft PowerPoint file | 0.74017 |
| Extreme Heat Older | 0.751517 |
| Carbon Monoxide Poisoning | 0.877735 |
| Vibrio vulnificus Wound | 0.730501 |
| Water Safe | 0.739683 |
| Winter Weather Checklists | 0.742172 |
| Evacuation Center Play | 0.745751 |
| Microsoft Word file | 0.743603 |
| Hot Weather Tips | 0.741497 |
| Control Infection Control | 0.72308 |
| Response Workers Health | 0.758893 |
| Natural Disasters | 0.722601 |
| Lightning Safety Tips | 0.762197 |
| Microsoft Excel file | 0.739118 |
| page options Skip | 0.756821 |
| Safety Food Safety | 0.813127 |
| different file formats | 0.741651 |
| Public Evacuation Centers | 0.757339 |
| Disaster Resources Educational | 0.768623 |
| Apple Quicktime file | 0.735615 |
| Missouri Cooling Centers | 0.73642 |
| Cold Weather Hypothermia | 0.72842 |
| Wildfires PSAs | 0.729848 |
| Building Water Systems | 0.737473 |
| Adobe PDF file | 0.736935 |
|
| Pressure Washer Safety | 0.743718 |
| Evacuation Centers | 0.86552 |
| Storm Indoor Safety | 0.759848 |
| Tsunamis Health Effects | 0.740713 |
| Social Media | 0.727358 |
| processing SSI file | 0.739857 |
| Winter Weather | 0.752879 |
| Search Form Controls | 0.862389 |
| Pesticide Safety Guidance | 0.749867 |
| Disaster Evacuation Centers | 0.793259 |
| Emergency Health Professionals | 0.754397 |
| Disaster Immunization Immunization | 0.75949 |
| Extreme Heat PSAs | 0.816382 |
| Outdoor Safety | 0.761917 |
| Extreme Heat | 0.99106 |
| outdoor workers | 0.733624 |
| Vulnerable Groups | 0.800172 |
| Search Controls | 0.750042 |
| Tsunami Worker Safety | 0.758587 |
| Floods PSAs | 0.730319 |
| Educational Materials | 0.818311 |
| Community Evacuation Centers | 0.758463 |
| Worker Safety | 0.847706 |
| Severe Weather | 0.722519 |
|
CLICK HERE |
| 6954 |
Centers for Disease Control and Prevention |
Html |
en |
CDC - Preventing Chronic Disease: Volume 9, 2012:11_0142 |
In Ethiopia, lack of reliable data on causes of death prevents full understanding of the double mortality burden of communicable and noncommunicable diseases. Our objective was to help bridge this research gap by analyzing surveillance data on causes of death in Addis Ababa. |
| epidemiological transition | 0.450659 |
| verbal autopsy interviews | 0.378409 |
| injuries | 0.397193 |
| premature death rate | 0.37135 |
| female deaths | 0.468894 |
| major causes | 0.37466 |
| World Bank | 0.382656 |
| standardized verbal autopsy | 0.377378 |
| deaths | 0.79482 |
| group | 0.432318 |
| burial surveillance records | 0.369716 |
| adult death rates | 0.382466 |
| World Health Organization | 0.412216 |
| digestive tract diseases | 0.582305 |
| Addis Ababa | 0.988385 |
| verbal autopsies | 0.530933 |
| verbal autopsy questionnaire | 0.412811 |
| Mortality Surveillance Program | 0.455029 |
| overall death rates | 0.38049 |
| Addis Ababa population | 0.49409 |
| death rates | 0.426895 |
| age-specific death rate | 0.381623 |
| Addis Ababa residents | 0.532789 |
| Ethiopia | 0.368765 |
| study | 0.453291 |
|
| death | 0.62983 |
| age group | 0.418825 |
| adults | 0.421231 |
| Addis Ababa Labour | 0.470651 |
| communicable diseases | 0.682389 |
| Addis Ababa University | 0.472553 |
| death rate | 0.395994 |
| typical mortality burden | 0.371307 |
| Premature deaths | 0.44455 |
| burial surveillance | 0.544258 |
| verbal autopsy | 0.492162 |
| causes | 0.508537 |
| premature death increases | 0.373169 |
| double mortality burden | 0.591632 |
| Addis Ababa Mortality | 0.543086 |
| Ababa Mortality Surveillance | 0.512489 |
| noncommunicable diseases | 0.914211 |
| CVD deaths | 0.417503 |
| Addis Ababa cemeteries | 0.489058 |
| adult deaths | 0.442934 |
| deceased Addis Ababa | 0.495084 |
| infant deaths | 0.41306 |
| malignant neoplasm | 0.413019 |
| proportional death rates | 0.3817 |
|
CLICK HERE |
| 9115 |
Centers for Disease Control and Prevention |
Html |
en |
Updated Recommendations for Use of VariZIG - United States,2013 |
Persons using assistive technology might not be able to fully access information in this file. For assistance, please send e-mail to: mmwrq@cdc.gov. |
| investigational VariZIG | 0.471713 |
| varicella-zoster antibodies | 0.484839 |
| zoster immune globulin | 0.985169 |
| CDC | 0.552424 |
| anti–varicella-zoster virus antibodies | 0.636061 |
| United States | 0.709311 |
| hospital care | 0.482718 |
| VariZIG Recommendations | 0.477859 |
| high levels | 0.484256 |
| severe varicella | 0.652174 |
| initial exposure | 0.485143 |
| human immune globulins | 0.491501 |
| initial VariZIG administration | 0.514786 |
| immune globulin products | 0.531379 |
| neonatal period | 0.481968 |
| varicella vaccine | 0.643472 |
| premature infants | 0.545128 |
| ACIP work group | 0.492729 |
| VariZIG | 0.745812 |
| herpes zoster | 0.572094 |
| susceptible immunocompromised children | 0.500008 |
| expert opinion | 0.477855 |
| varicella zoster | 0.822512 |
| patient groups | 0.604152 |
|
| patients | 0.476845 |
| immunocompromised children | 0.512021 |
| IND protocol | 0.478866 |
| immune globulins | 0.537549 |
| varicella incidence | 0.578211 |
| varicella complications | 0.572399 |
| investigational new drug | 0.481479 |
| varicella | 0.926009 |
| postnatally acquired varicella | 0.607907 |
| high anti–varicella-zoster virus | 0.491303 |
| clinical varicella | 0.652671 |
| postexposure prophylaxis | 0.487966 |
| varicella-zoster virus | 0.891342 |
| entire period | 0.479394 |
| commercial varicella zoster | 0.65435 |
| exposure | 0.665782 |
| high risk | 0.559179 |
| cdc recommendations | 0.533704 |
| immune globulin preparation | 0.7232 |
| varizig administration | 0.666998 |
| varicella-zoster virus exposure | 0.592069 |
| household exposure | 0.509973 |
| volunteer blood donors | 0.474575 |
|
CLICK HERE |
| 12842 |
Centers for Disease Control and Prevention |
Html |
en |
Vaccine Storage|Natural Disasters and Severe Weather |
Information on disasters. Provided by the Centers for Disease Control and Prevention (CDC). |
| family… | 0.339238 |
| Guide | 0.335933 |
| charcoal grills | 0.649458 |
| carbon monoxide | 0.950552 |
| General info | 0.582777 |
| hurricane | 0.369657 |
| steps | 0.367412 |
| flood | 0.369387 |
| food | 0.342904 |
|
| heat-related illness | 0.64169 |
| water safety | 0.580568 |
| aftermath | 0.380931 |
| heat stress | 0.542196 |
| camp stoves | 0.599626 |
| powerline hazards | 0.69177 |
| carbon monoxide poisoning | 0.935865 |
| Extreme Heat Prevention | 0.74894 |
|
CLICK HERE |
| 13201 |
Centers for Disease Control and Prevention |
Html |
en |
Announcement: CDC-Sponsored Continuing Education Courses onScreening for Colorectal Cancer |
Colorectal cancer is the second leading cancer killer in the United States. Screening for colorectal cancer saves lives, but problems with its implementation in clinical practice can reduce screening's effectiveness. |
| CDC-sponsored continuing education | 0.648923 |
| endorsement | 0.399693 |
| Human Services | 0.637746 |
| leaders | 0.329283 |
| research | 0.329228 |
| U.S. Department | 0.632227 |
| MMWR HTML versions | 0.622939 |
| primary care providers | 0.642609 |
| education credits | 0.481567 |
| physicians | 0.328979 |
| electronic PDF version | 0.602772 |
| colorectal cancer screening | 0.798357 |
| health professionals | 0.490799 |
| courses | 0.357828 |
| colorectal cancer | 0.980273 |
| lives | 0.332273 |
| Contact GPO | 0.514566 |
| maximum benefit | 0.480483 |
| patients | 0.33008 |
| commercial sources | 0.477806 |
| primary care clinicians | 0.683504 |
| current prices | 0.467503 |
| original paper copy | 0.599882 |
| problems | 0.332244 |
|
| best ways | 0.488882 |
| nationally recognized experts | 0.631776 |
| United States | 0.503722 |
| U.S. Government Printing | 0.600959 |
| clinical practice | 0.501541 |
| Superintendent | 0.334044 |
| tools | 0.330219 |
| MMWR readers | 0.484208 |
| character translation | 0.46652 |
| MMWR paper copy | 0.612345 |
| course | 0.3298 |
| format errors | 0.473712 |
| effectiveness | 0.329715 |
| colonoscopy procedures | 0.501572 |
| implementation | 0.332215 |
| typeset documents | 0.480424 |
| public health programs | 0.646845 |
| trade names | 0.477975 |
| official text | 0.463841 |
| cancer killer | 0.518773 |
| non-CDC sites | 0.475306 |
| http://www.cdc.gov/cancer/colorectal/quality | 0.329565 |
| electronic conversions | 0.466122 |
| printable versions | 0.464393 |
|
CLICK HERE |
| 13246 |
Centers for Disease Control and Prevention |
Html |
en |
CDC Community Health Improvement Navigator | CDC Features |
Invest in Your Community: Improve Health and Well-Being for All |
| stakeholders expert-vetted tools | 0.402206 |
| IRS Final Rule | 0.544794 |
| Service Final Rule | 0.35147 |
| online CHI Navigator | 0.477816 |
| community stakeholders | 0.405849 |
| Health Needs Assessments | 0.72902 |
| Collaborative CHI section | 0.418676 |
| collaborative CHI process | 0.370967 |
| targeted tools | 0.240755 |
| Disease Control | 0.241905 |
| brief vignettes highlight | 0.355698 |
| health behaviors | 0.301336 |
| health systems | 0.618767 |
| high-priority actions | 0.245559 |
| population health | 0.296303 |
| greater impact | 0.357925 |
| Asked Questions section | 0.359929 |
| economic vitality | 0.243892 |
| Excise Tax Return | 0.319892 |
| community health | 0.916758 |
| adequate nutrition—and | 0.228738 |
| relevant quotations | 0.230905 |
| public health agencies | 0.632349 |
| Community Health Needs | 0.720483 |
|
| community health systems | 0.451256 |
| collaborative CHI work | 0.414127 |
| Charitable Hospitals | 0.573209 |
| Key target audiences | 0.33202 |
| fact sheets | 0.234992 |
| patient outcomes | 0.228389 |
| action areas | 0.359102 |
| Interventions section | 0.277073 |
| potential partners | 0.237492 |
| health departments | 0.304765 |
| health care | 0.588331 |
| community organizations | 0.281314 |
| community partners | 0.282665 |
| clinical care | 0.232919 |
| Review information | 0.234377 |
| CHI Efforts section | 0.410008 |
| CHI process | 0.438213 |
| CHI Navigator | 0.93956 |
| collaborative chi | 0.449364 |
| community health assessment | 0.466575 |
| health care sector | 0.417083 |
| sustainable financial model | 0.328748 |
| greatest impact | 0.237523 |
| Community health improvement | 0.516138 |
|
CLICK HERE |
| 16201 |
Centers for Disease Control and Prevention |
Html |
en |
Vaccines: Vaccine-Preventable Adult Diseases |
Learn About Serious Diseases that Can Be Prevented by Vaccines. |
| contagious bacterial disease | 0.429605 |
| United States | 0.402043 |
| chronic health conditions | 0.464897 |
| Diphtheria Vaccination page | 0.458127 |
| hepatitis B virus | 0.384482 |
| pneumococcal disease | 0.390679 |
| fever | 0.431417 |
| certain chronic health | 0.462515 |
| Measles Vaccination page | 0.453615 |
| Vaccination page | 0.907577 |
| prolonged cold symptoms | 0.382976 |
| Hepatitis A Vaccination | 0.412468 |
| HPV Vaccination page | 0.453676 |
| sexually transmitted infections | 0.391633 |
| Hepatitis B Vaccination | 0.410565 |
| certain health conditions | 0.391738 |
| sore throat | 0.399679 |
| mild illness | 0.395447 |
| chronic liver disease | 0.410655 |
| spinal cord | 0.428944 |
| respiratory tract infection | 0.39504 |
| pneumococcal conjugate vaccine | 0.47051 |
| Mumps Vaccination page | 0.44449 |
| disease | 0.546541 |
|
| sudden high fever | 0.411813 |
| permanent hearing loss | 0.388228 |
| painful skin rash | 0.411477 |
| mumps virus | 0.394983 |
| joint pain | 0.395373 |
| itchy rash | 0.378016 |
| severe liver diseases | 0.409954 |
| brain damage | 0.389746 |
| cervical cancer | 0.403354 |
| severe skin infections | 0.423194 |
| hepatitis A virus | 0.385642 |
| meningococcal disease | 0.456105 |
| whooping cough | 0.423463 |
| severe health problems | 0.400633 |
| low-grade fever | 0.378103 |
| hepatitis B infection | 0.381889 |
| contagious viral infection | 0.41324 |
| varicella zoster virus | 0.506347 |
| Meningococcal Vaccination page | 0.454393 |
| information | 0.480903 |
| Pneumococcal Vaccination page | 0.440599 |
| pneumococcal polysaccharide vaccine | 0.457698 |
| severe illness | 0.405591 |
|
CLICK HERE |